Expand Energy started with Outperform rating at J.P. Morgan, citing large-scale exposure to natural gas as the largest producer in the U.S. and the trend of growing natgas demand.

is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

Fintel reports that on January 16, 2025, JP Morgan initiated coverage of Expand Energy (NasdaqGS:EXE) with a Overweight recommendation. Price T Rowe Associates holds 14,203K shares representing 6. ...

Ollie's Bargain Outlet Holdings (NASDAQ:OLLI) was one of the biggest gainers in the consumer sector on Thursday after J.P. Morgan added the stock to its Analyst Focus List on its view the retailer ...

Shares of Kymera Therapeutics (NASDAQ:KYMR) spiked on Tuesday after the developer of oral protein degraders outlined its 2025 ...

He cut Federated Hermes ( NYSE: FHI) to Neutral from Overweight, partly due to lost market share in money funds and partly ...

today announced that it will participate in the J.P. Morgan 43rd Annual Healthcare Conference, January 12-16, 2025. BioUtah President and CEO, Kelvyn Cullimore, will attend on behalf of the ...

WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 43rd Annual J.P. Morgan Healthcare Conference ...

I am pleased to announce that Sotera Health delivered another year of top-line growth in 2024,” said Mr. Petras. “We expect full-year revenues will be approximately $1.1 billion, representing growth ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative ... will present at the 43rd Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT on Thursday ...

Shares of Kymera Therapeutics (NASDAQ:KYMR) spiked on Tuesday after the developer of oral protein degraders outlined its 2025 outlook at the ongoing J.P. Morgan Healthcare Conference. According to ...